McKesson SG&A Expenses 2012-2026 | MCK
McKesson annual/quarterly sg&a expenses history and growth rate from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- McKesson sg&a expenses for the quarter ending March 31, 2026 were $1.796B, a 9.06% decline year-over-year.
- McKesson sg&a expenses for the twelve months ending March 31, 2026 were $8.096B, a 4.83% decline year-over-year.
- McKesson annual sg&a expenses for 2026 were $8.096B, a 4.83% decline from 2025.
- McKesson annual sg&a expenses for 2025 were $8.507B, a 1.73% decline from 2024.
- McKesson annual sg&a expenses for 2024 were $8.657B, a 11.33% increase from 2023.
|
McKesson Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026 | $8,096 |
| 2025 | $8,507 |
| 2024 | $8,657 |
| 2023 | $7,776 |
| 2022 | $10,537 |
| 2021 | $8,849 |
| 2020 | $9,182 |
| 2019 | $8,437 |
| 2018 | $8,138 |
| 2017 | $7,447 |
| 2016 | $7,379 |
| 2015 | $7,901 |
| 2014 | $5,388 |
| 2013 | $4,110 |
| 2012 | $3,727 |
|
McKesson Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1,796 |
| 2025-12-31 | $2,030 |
| 2025-09-30 | $2,074 |
| 2025-06-30 | $2,196 |
| 2025-03-31 | $1,975 |
| 2024-12-31 | $2,028 |
| 2024-09-30 | $2,503 |
| 2024-06-30 | $2,001 |
| 2024-03-31 | $2,189 |
| 2023-12-31 | $2,506 |
| 2023-09-30 | $2,092 |
| 2023-06-30 | $1,870 |
| 2023-03-31 | $1,964 |
| 2022-12-31 | $1,903 |
| 2022-09-30 | $1,950 |
| 2022-06-30 | $1,959 |
| 2022-03-31 | $2,531 |
| 2021-12-31 | $3,105 |
| 2021-09-30 | $2,669 |
| 2021-06-30 | $2,232 |
| 2021-03-31 | $2,224 |
| 2020-12-31 | $2,291 |
| 2020-09-30 | $2,237 |
| 2020-06-30 | $2,097 |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $106.025B | $359.051B |
| McKesson Corporation distributes pharmaceuticals, medical-surgical supplies and health and beauty care products principally in North America. The Company also develops, implements and supports software which facilitates the integration of data throughout the health enterprise. McKesson Corporation is based in IRVING, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |